Skip to content
Home

Placebo: inert treatments, the placebo effect, and their role in medicine

Overview of placebos — inactive treatments used in research and sometimes care; how placebo effects arise, history, uses in trials, ethical concerns, and related phenomena such as the nocebo effect.

Overview

A placebo is an intentionally inactive treatment given to a person as if it were an active medical intervention. Common forms include sugar pills, saline injections, or sham procedures that mimic a real intervention without delivering its therapeutic component. Placebos are used primarily to compare real treatments against a control, and sometimes to study how belief and context influence recovery from a disease or health condition.

Image gallery

3 Images

Forms and distinguishing features

Placebos are defined by their lack of specific therapeutic action for the target condition. Typical categories include:

  • Oral inert agents such as sugar pills or capsules.
  • Injections of saline or other non-active fluids.
  • Sham devices or procedures that reproduce the steps of an intervention without its effective element.
  • Open-label placebos, where a patient is informed they are receiving a placebo but still may experience benefit.

How placebo effects arise

The observable improvement following a placebo is called the placebo effect or placebo response. It arises from psychological and physiological processes rather than a direct action of the inert substance. Contributing factors include expectation of benefit, prior conditioning (learning), the patient–clinician interaction, and contextual cues such as ritual and appearance of treatment. Neurobiological research has linked some placebo responses to measurable changes in brain activity and neurochemistry; for example, endogenous opioid and dopamine systems can be involved in pain and reward-related placebo responses.

History and role in clinical research

The concept and term "placebo effect" entered medical discussion in the early 20th century and became central to the development of controlled clinical trials. Placebo-controlled, randomized and blinded trials help determine whether an observed benefit is due to a treatment's specific action or to non-specific influences such as expectation. Double-blind placebo-controlled trials remain a standard method for evaluating efficacy and safety of new therapies.

Uses, examples, and distinctions

Placebos serve as controls in research, allowing investigators to quantify the additional benefit of an active treatment. Clinically, placebos have occasionally been used when no proven therapy exists or in situations where symptom relief may arise from non-specific effects. It is important to distinguish the placebo response (all improvements seen in the placebo group) from the placebo effect (the component of response attributed to psychological or contextual factors). The related nocebo effect refers to negative outcomes produced by negative expectations.

Ethical and practical considerations

Using placebos raises ethical questions, especially when deceiving patients would deny them effective treatment. In research, ethical oversight, informed consent, and use of placebos only when appropriate are required. Debates continue about the acceptability of placebo use in practice; alternatives such as open-label placebos and maximizing therapeutic communication are being explored as ways to harness beneficial non-specific effects while respecting patient autonomy.

Notable facts: placebo responses vary widely between conditions and individuals, can be influenced by treatment presentation, and are a legitimate subject of scientific study for understanding mind–body interactions.

Etymology

The term placebo comes from the Christian liturgy. The Latin verse Placebo domino in regione vivorum (Ps 114:9 Vul) of the Vulgate translation of the Church Father Jerome, which follows the Hebrew text, reads in Luther's translation "I will walk before the Lord in the land of the living." (Ps 116:9 Lut84) - thus agreeing with the Vulgate translation. In the Septuagint, the ancient Greek translation of the Old Testament, on the other hand, the Hebrew verb for "go" or "walk" is not translated literally, but in a figurative sense. To this corresponds the Latin translation of Jerome after the Greek with the verb form "placebo"; the German translation of this verse reads accordingly: "I will please the Lord in the land of the living".

The derogatory idiom "to sing someone a placebo" derives from the funeral rite of the Catholic Church. The cause of this change in meaning in the late Middle Ages is thought to be, among other things, the changes in the design of the funeral service, which made it possible for the alternate chanting of this Vulgate verse to be intoned by paid singers and no longer just by the mourners themselves. "Placebo" was thus seen as something hypocritical, a flattering and spurious substitute performance.

Finally, in the 18th century, "placebo" became part of the medical vocabulary in its common meaning. The first lexical definition of the word was given by George Motherby in A New Medical Dictionary; or, General Repository of Physics (1775).

Insert

Research

Placebos are used in research. Placebo-controlled, double-blind, randomized studies are used to closely examine the therapeutic efficacy of drugs. One part of the subjects receives the drug to be tested (verum), while the control group receives a placebo (identical in appearance, taste and, if necessary, side effects of the verum). A difference between the measured effects in both groups in favour of the verum can thus be regarded as its efficacy. This effect of the verum may be larger or smaller than the placebo effect. The statistical significance of the effect found in scientific studies and in favour of the verum (which in this context must necessarily be distinguished from the relevance of the effect of the verum) is one of the most important prerequisites for the approval of a drug by the competent health authorities.

  • Double-blind studies are those in which neither the doctor nor the patients know whether placebo or verum was administered. This eliminates the possibility of influencing the outcome. The double-blind approach can pose challenges to the conduct of studies in which the verum is not in a form that can be easily converted to placebo. Their execution may then be imperfectly realized.
  • Randomised means that the control group is determined by chance, for example by drawing lots. This avoids factors such as the stage of the disease being included unconsciously.

Placebotherapy

The placebo effect has a more or less large share in every treatment success. Pure or complementary placebo therapies are also not infrequently used in clinical practice. The administration of placebos for the treatment of complaints is ethically controversial. Especially in pain therapy, placebo effects can strongly support the treatment in a positive way.

How effective placebo effects can be for certain symptoms is shown by a study of patients with irritable bowel syndrome who received three placebo treatments of different intensities. The first group was studied only, the second received sham acupuncture and the last sham acupuncture in combination with empathic, attentive, trusting conversations. In the group with sham acupuncture, the symptomatology improved significantly compared to the untreated group, and in the group with sham acupuncture and additional talks, the improvement in symptomatology was once again significantly greater than in the group treated with sham acupuncture only.

The placebo researcher Bertrand Graz considers the correlation between the positive expectations of the physician and the healing success of a treatment to be so significant that he proposes a new name for this effect factor, curabo effect (curabo: Latin for "I will heal"), instead of placebo (Latin for "I will please").

According to a number of scientists, the placebo effect cannot be equated with spontaneous healing, even though it is suspected that similar biochemical processes can be observed in both. In a spontaneous cure, the body eliminates the disease without any knowing outside help. In the placebo effect, on the other hand, the body is stimulated by external influences that are supposed to have a reinforcing effect on healing. This thesis is opposed by the opposite opinion, according to which the placebo effect is exclusively due to spontaneous remission, natural fluctuation of symptoms and subjective influence of the results on the part of doctors and patients (see below).

Further areas of application

Another area of application in clinical practice is the maintenance of intake habits for an active substance that is administered intermittently (a typical example is the contraceptive pill, where one week per cycle the active substance is suspended).

Questions and answers

Q: What is a placebo?

A: A placebo is a treatment for a disease or condition which is deliberately ineffective.

Q: What is the motive behind giving a placebo?

A: The motive behind giving a placebo is to make a person believe that a medicine, diet or other treatment is good for them.

Q: What is the "placebo effect"?

A: The placebo effect is when sick people who receive a placebo feel like they are getting better, and sometimes their bodies actually do get better.

Q: When was the term "placebo effect" introduced?

A: The term "placebo effect" (or placebo response) was introduced in 1920.

Q: What causes the observed effect in the placebo effect?

A: The response of the subject causes the observed effect in the placebo effect, not the substance.

Q: Is a placebo treatment effective in curing a disease?

A: No, a placebo treatment is deliberately ineffective in curing a disease.

Q: Can a person's belief in a treatment help them get better?

A: Yes, sometimes a person's belief in a treatment can help them get better.

Related articles

Author

AlegsaOnline.com Placebo: inert treatments, the placebo effect, and their role in medicine

URL: https://en.alegsaonline.com/art/77191

Share

Sources